Severe Disseminated Mycobacterium kansasii Infection due to Autoantibodies Against IFN-ɣ
暂无分享,去创建一个
[1] J. Brożek,et al. Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline. , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[2] T. Mio,et al. Case Report: Disseminated Mycobacterium kansasii Disease in a Patient with Anti-IFN-Gamma Antibody. , 2019, The American journal of tropical medicine and hygiene.
[3] E. Chan,et al. Acquired and genetic host susceptibility factors and microbial pathogenic factors that predispose to nontuberculous mycobacterial infections. , 2018, Current opinion in immunology.
[4] Chi-Yuan Li,et al. Anti-IFN-γ autoantibodies in adults with disseminated nontuberculous mycobacterial infections are associated with HLA-DRB1*16:02 and HLA-DQB1*05:02 and the reactivation of latent varicella-zoster virus infection. , 2013, Blood.